Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Sunitinib and Pazopanib in Metastatic Renal Cell Carcinoma
2012-001415-23Phase 4Completed
- Sponsor
- Central European Society for Anticancer Drug Research
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sunitinib and pazopanib in metastatic renal cell carcinoma (mRCC), sponsored by Central European Society for Anticancer Drug Research. Started Jul 2012; status: completed.
02
Drugs
sunitinibpazopanib
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on 2012-001415-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001415-23.